Pharmafile Logo
Pharmafocus logo
Advanced Search

Phase III trial supports the potential use of Cabometyx for thyroid cancer

June 8, 2021
Manufacturing and Production

Ipsen and Exelixis have announced detailed results from the Phase III COSMIC-311 pivotal trial of Cabozantinib in patients with previously …

News
hand-3666974_1280

FDA approves first new Alzheimer’s drug in two decades

June 8, 2021
Manufacturing and Production

Biogen’s controversial new drug, aducanumab, has been accepted by the FDA, making it the first Alzheimer’s drug to be approved …

News
img_4190-e1376666350337-web

MHRA approves venetoclax as acute myeloid leukemia treatment

June 8, 2021
Manufacturing and Production EC, EU, MHRA, leukemia

The MHRA has announced its approval for AbbVie’s venetoclax, in combination with a hypomethylating agent, for the treatment of newly …

News
merckwindow_web

MSD announce new data from advanced renal cell carcinoma trial

June 8, 2021
Manufacturing and Production MSD, rcc

Merk (MSD) has announced positive data from its Phase III Clear/Keynote-581 trial on Keytruda (pembrolizumab) plus Lenvima (lenvatinib), and Lenvima …

News

New NICE recommendation for Astellas prostate cancer drug

June 8, 2021
Manufacturing and Production Astellas, NICE, prostate cancer

A newly published Final Appraisal Determination by NICE has recommended Astellas’ Xtandi (enzalutamide) plus androgen deprivation therapy (ADT), as an …

News

Astronomy & cancer: Researchers join forces to study CUP

June 7, 2021
Sales and Marketing oncology

Astronomers from Durham University have joined forces with cancer researchers to advance the diagnosis and treatment of cancer of unknown …

News

UK vaccination update

June 7, 2021
Sales and Marketing

With 21 June fast approaching, and the Delta variant rising in the UK, here’s the latest vaccine update. Firstly, the …

News

AstraZeneca vs GSK: Cancer drug court battle could cost hundreds of millions

June 7, 2021
Sales and Marketing AstraZeneca, GSK, court

AstraZeneca has launched a court case against Glaxo Smith Kline (GSK), in a claim that could reach hundreds of millions …

News
covid_cell_1_20

MHRA confirms registration of Avacta’s lateral flow test

June 7, 2021
Sales and Marketing COVID-19, EU, MHRA, lateral flow test

Avacta has announced that the MHRA has confirmed registration of the AffiDX SARS-CoV-2 antigen lateral flow test, which allows the …

News
regeneron

Regeneron’s COVID-19 antibody EUA reduced to lower dose by FDA

June 7, 2021
Sales and Marketing

The FDA has updated the Emergency Use Authorisation (EUA) for Regeneron Pharmaceuticals’ COVID-19 antibody cocktail, REGEN-COV, halving the dose from …

News
top_10_image_2_9

Pharmafile.com’s top 10 news stories of the week

June 4, 2021
Medical Communications

Among our ten most-read stories this week: NICE rejects risdiplam for treating spinal muscular atrophy; The EU wants to Fine …

News
novartis_window

Novartis’s 177Lu-PSMA-617 reduces prostate cancer death risk by 38%

June 4, 2021
Medical Communications

Novartis’s 177Lu-PSMA-617 has shown to significantly improve overall survival and radiographic progression-free survival for men with metastatic castration-resistant prostate cancer …

News

BMS announce new positive data from oesophageal cancer study

June 4, 2021
Medical Communications Cancer, oncology

Bristol Myers Squibb (BMS) has announced results from the Phase III CheckMate -648 trial in which nivolumab plus chemotherapy and …

News

Phase III trial shows Olaparib reduces breast cancer recurrence by 42%

June 4, 2021
Medical Communications

Results from OlympiA’s Phase III trial has shown that its Olaparib (Lynparza) in the adjuvant treatment of patients with germline …

News

J&J’s Tremfya sees positive results for post-TNFi psoriatic arthritis

June 4, 2021
Medical Communications J&J, JJ

Johnson & Johnson’s interleukin-23 (IL-23) Tremfya (guselkumab) has shown positive results in Phase IIIb trials, in post-tumour necrosis factor (TNF) …

News
cdc-un8tv9pw2ik-unsplash_1

WHO approves China’s Sinovac COVID-19 vaccine

June 3, 2021

China’s Sinovac COVID-19 vaccination has received an emergency use listing (EUL) from the WHO. This decision means the jab can …

News
hd_map

Vaccine patch outperforms needle-and-syringe jabs in pre-clinical study

June 3, 2021
COVID-19, Vaccine, technology

Vaxxas, an Australian clinical-stage biotechnology company, has announced positive results from pre-clinical trials into its novel high-density microarray patch (HD-MAP) …

News

Phase III traumatic brain injury trial does not meet primary endpoint

June 3, 2021

vasopharm GmbH has announced that its NOSTRA III traumatic brain injury (TBI) Phase III clinical trial of ronopterin did not …

News

Novartis report longest median OS in breast cancer study

June 3, 2021
Novartis, breast cancer, trials

Novartis has announced updated median overall survival (OS) results for Kisqali (ribociclib), in combination with fulvestrant, in postmenopausal women with …

News

Organon launches as women’s health company

June 3, 2021

Organon has today launched through a spinoff from Merck as a global company focusing on women’s health. The new team …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026